Imatinib in the first-line treatment of chronic myelogenous leukemia in chronic phase

Abstract

Imatinib in the first-line treatment of chronic myelogenous leukemia in chronic phase

Keywords

• Chronic myelogenous leukemia
• imatinib
• treatment